Neurovascular Product Surveillance Registry
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Intracranial Aneurysm
- Stroke Ischemic
- Design
- Observational Model: CohortTime Perspective: Prospective
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
An observational, prospective, multi-center, single-arm registry to provide continuing evaluation and periodic reporting of safety and effectiveness of Medtronic Neurovascular market-released products used in the treatment of Intracranial aneurysms and Acute Ischemic Stroke.
An observational, prospective, multi-center, single-arm registry to provide continuing evaluation and periodic reporting of safety and effectiveness of Medtronic Neurovascular market-released products used in the treatment of Intracranial aneurysms and Acute Ischemic Stroke.
Tracking Information
- NCT #
- NCT02988128
- Collaborators
- Medtronic Bakken Research Center
- Investigators
- Study Chair: Markus Holtmannspotter, MD Klinikum Nürnberg Süd Study Chair: Laurent Spelle, MD Hôpital Bicêtre, Service de Neuroradiologie Interventionnelle Adulte et Pédiatrique Study Chair: Jens Fiehler, MD Universitätsklinikum Hamburg-Eppendorf Study Chair: István Szikora, MD National Institute of Clinical Neurosciences Study Chair: Mario Galdamez, MD Hospital Clínico Universitario de Valladolid Study Chair: Saleh Lamin, MD Queen Elisabeth Hospital, Neuroradiology Study Chair: Francis Turjman, MD Hôpital Pierre Wertheimer Study Chair: Christophe Cognard, MD CHU Toulouse - Hôpital Purpan Study Chair: Markus Möhlenbruch, MD University Hospital Heidelberg Study Chair: Marc Ribó, MD Hospital Vall d'Hebron Study Chair: Pasquale Mordasini, MD Inselspital - Universitätsspital Bern Study Chair: Sanjeev Nayak, MD University Hospitals of North Midlands NHS Trust - Royal Stoke University Hospital
Get Well Soon